Our findings indicate that plasma levels of P-tau181, NfL, and GFAP significantly contribute to predicting cognitive decline and the risk of progressing to clinically-diagnosed DAT, while Aβ42/Aβ40 ratio appears to be more useful in predicting the risk of progression to clinically-diagnosed DAT. The gene discussed is GFAP; the disease is Mental deterioration.